More than the sum of its parts? Nutrition in Alzheimer's disease

Nutrition

Volumn 26, Issue 7-8, 2010, Pages 694-700

  von Arnim, Christine A F ^a   Gola, Ute ^b   Biesalski, Hans K ^b  

^a UNIVERSITY OF ULM   (Germany)

^b UNIVERSITY OF HOHENHEIM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; BETA CAROTENE; CARNITINE; CYANOCOBALAMIN; DOCOSAHEXAENOIC ACID; DONEPEZIL; FOLIC ACID; GINKGO BILOBA EXTRACT; HOMOCYSTEINE; MAGNESIUM; OMEGA 3 FATTY ACID; PLACEBO; POLYUNSATURATED FATTY ACID; PYRIDOXINE; SELEGILINE; SELENIUM; TRACE ELEMENT; VITAMIN D;

ALZHEIMER DISEASE; BRAIN ATROPHY; CLINICAL TRIAL; COGNITIVE DEFECT; DECISION MAKING; DEMENTIA; DIETARY INTAKE; DRUG EFFICACY; HUMAN; HYPERHOMOCYSTEINEMIA; INTERPERSONAL COMMUNICATION; LEARNING; MALNUTRITION; NONHUMAN; NUTRITION; OBESITY; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SOCIOECONOMICS; SUPPLEMENTATION; WEIGHT REDUCTION;

ALZHEIMER DISEASE; ANTIOXIDANTS; DEFICIENCY DISEASES; HUMANS; MICRONUTRIENTS; OXIDATIVE STRESS; VITAMIN B COMPLEX;

EID: 77953809951     PISSN: 08999007     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nut.2009.11.009     Document Type: Review

References (82)

1. Luchsinger J.A., Gustafson D.R. Adiposity, type 2 diabetes, and Alzheimer's disease. J Alzheimers Dis 2009, 16:693-704.
2. Hassing L.B., Dahl A.K., Thorvaldsson V., Berg S., Gatz M., Pedersen N.L., et al. Overweight in midlife and risk of dementia: a 40-year follow-up study. Int J Obes (Lond) 2009, 33(8):893-898.
3. Kivipelto M., Ngandu T., Fratiglioni L., Viitanen M., Kareholt I., Winblad B., et al. Obesity and vascular risk factors at midlife and the risk of dementia and Alzheimer disease. Arch Neurol 2005, 62:1556-1560.
4. Whitmer R.A., Gustafson D.R., Barrett-Connor E., Haan M.N., Gunderson E.P., Yaffe K. Central obesity and increased risk of dementia more than three decades later. Neurology 2008, 71:1057-1064.
5. Colman R.J., Anderson R.M., Johnson S.C., Kastman E.K., Kosmatka K.J., Beasley T.M., et al. Caloric restriction delays disease onset and mortality in rhesus monkeys. Science 2009 Jul 10, 325:201-204.
6. Vellas B.J., Hunt W.C., Romero L.J., Koehler K.M., Baumgartner R.N., Garry P.J. Changes in nutritional status and patterns of morbidity among free-living elderly persons: a 10-year longitudinal study. Nutrition 1997, 13:515-519.
7. Fitzpatrick A.L., Kuller L.H., Lopez O.L., Diehr P., O'Meara E.S., Longstreth W.T., et al. Midlife and late-life obesity and the risk of dementia: cardiovascular health study. Arch Neurol 2009, 66:336-342.
8. Vellas B., Guigoz Y., Garry P.J., Nourhashemi F., Bennahum D., Lauque S., et al. The Mini Nutritional Assessment (MNA) and its use in grading the nutritional state of elderly patients. Nutrition 1999, 15:116-122.
9. Ousset P.J., Nourhashemi F., Reynish E., Vellas B. Nutritional status is associated with disease progression in very mild Alzheimer disease. Alzheimer Dis Assoc Disord 2008, 22:66-71.
10. Dumont C., Voisin T., Nourhashemi F., Andrieu S., Koning M., Vellas B. Predictive factors for rapid loss on the mini-mental state examination in Alzheimer's disease. J Nutr Health Aging 2005, 9:163-167.
11. Spaccavento S., Del Prete M., Craca A., Fiore P. Influence of nutritional status on cognitive, functional and neuropsychiatric deficits in Alzheimer's disease. Arch Gerontol Geriatr 2009, 48:356-360.
12. Salva A., Andrieu S., Fernandez E., Schiffrin E.J., Moulin J., Decarli B., et al. Health and Nutritional Promotion Program for Patients with Dementia (NutriAlz Study): design and Baseline Data. J Nutr Health Aging 2009, 13:529-537.
13. Barberger-Gateau P., Raffaitin C., Letenneur L., Berr C., Tzourio C., Dartigues J.F., et al. Dietary patterns and risk of dementia: the three-city cohort study. Neurology 2007, 69:1921-1930.
14. Scarmeas N., Stern Y., Tang M.X., Mayeux R., Luchsinger J.A. Mediterranean diet and risk for Alzheimer's disease. Ann Neurol 2006, 59:912-921.
15. Scarmeas N., Stern Y., Mayeux R., Manly J.J., Schupf N., Luchsinger J.A. Mediterranean diet and mild cognitive impairment. Arch Neurol 2009, 66:216-225.
16. Scarmeas N., Luchsinger J.A., Mayeux R., Stern Y. Mediterranean diet and Alzheimer disease mortality. Neurology 2007, 69:1084-1093.
17. Eskelinen M.H., Ngandu T., Helkala E.L., Tuomilehto J., Nissinen A., Soininen H., et al. Fat intake at midlife and cognitive impairment later in life: a population-based CAIDE study. Int J Geriatr Psychiatry 2008, 23:741-747.
18. Devore E.E., Stampfer M.J., Breteler M.M., Rosner B., Hee Kang J., Okereke O., et al. Dietary fat intake and cognitive decline in women with type 2 diabetes. Diabetes Care 2009, 32:635-640.
19. Cole G.M., Lim G.P., Yang F., Teter B., Begum A., Ma Q., et al. Prevention of Alzheimer's disease: Omega-3 fatty acid and phenolic anti-oxidant interventions. Neurobiol Aging 2005, 26(suppl 1):133-136.
20. Lim G.P., Calon F., Morihara T., Yang F., Teter B., Ubeda O., et al. A diet enriched with the omega-3 fatty acid docosahexaenoic acid reduces amyloid burden in an aged Alzheimer mouse model. J Neurosci 2005, 25:3032-3040.
21. Ma Q.L., Yang F., Rosario E.R., Ubeda O.J., Beech W., Gant D.J., et al. Beta-amyloid oligomers induce phosphorylation of tau and inactivation of insulin receptor substrate via c-Jun N-terminal kinase signaling: suppression by omega-3 fatty acids and curcumin. J Neurosci 2009, 29:9078-9089.
22. Devore E.E., Grodstein F., van Rooij F.J., Hofman A., Rosner B., Stampfer M.J., et al. Dietary intake of fish and omega-3 fatty acids in relation to long-term dementia risk. Am J Clin Nutr 2009, 90:170-176.
23. Freund-Levi Y., Eriksdotter-Jonhagen M., Cederholm T., Basun H., Faxen-Irving G., Garlind A., et al. Omega-3 fatty acid treatment in 174 patients with mild to moderate Alzheimer disease: OmegAD study: a randomized double-blind trial. Arch Neurol 2006, 63:1402-1408.
24. Das U.N. Long-chain polyunsaturated fatty acids in the growth and development of the brain and memory. Nutrition 2003, 19:62-65.
25. Kolosova N.G., Shcheglova T.V., Sergeeva S.V., Loskutova L.V. Long-term antioxidant supplementation attenuates oxidative stress markers and cognitive deficits in senescent-accelerated OXYS rats. Neurobiol Aging 2006, 27:1289-1297.
26. Cao C., Cirrito J.R., Lin X., Wang L., Verges D.K., Dickson A., et al. Caffeine suppresses amyloid-beta levels in plasma and brain of Alzheimer's disease transgenic mice. J Alzheimers Dis 2009, 17:681-697.
27. Mandel S.A., Amit T., Kalfon L., Reznichenko L., Weinreb O., Youdim M.B. Cell signaling pathways and iron chelation in the neurorestorative activity of green tea polyphenols: special reference to epigallocatechin gallate (EGCG). J Alzheimers Dis 2008, 15:211-222.
28. Shukitt-Hale B., Kalt W., Carey A.N., Vinqvist-Tymchuk M., McDonald J., Joseph J.A. Plum juice, but not dried plum powder, is effective in mitigating cognitive deficits in aged rats. Nutrition 2009, 25:567-573.
29. Karuppagounder S.S., Pinto J.T., Xu H., Chen H.L., Beal M.F., Gibson G.E. Dietary supplementation with resveratrol reduces plaque pathology in a transgenic model of Alzheimer's disease. Neurochem Int 2009, 54:111-118.
30. Luo Y., Smith J.V., Paramasivam V., Burdick A., Curry K.J., Buford J.P., et al. Inhibition of amyloid-beta aggregation and caspase-3 activation by the Ginkgo biloba extract EGb761. Proc Natl Acad Sci U S A 2002, 99:12197-12202.
31. Eskelinen M.H., Ngandu T., Tuomilehto J., Soininen H., Kivipelto M. Midlife coffee and tea drinking and the risk of late-life dementia: a population-based CAIDE study. J Alzheimers Dis 2009, 16:85-91.
32. 2-isoprostanes and the risk of Alzheimer's disease and dementia: a prospective population-based study. J Alzheimers Dis 2009, 18(1):71-78.
33. Kamat C.D., Gadal S., Mhatre M., Williamson K.S., Pye Q.N., Hensley K. Antioxidants in central nervous system diseases: preclinical promise and translational challenges. J Alzheimers Dis 2008, 15:473-493.
34. Kang J.H., Irizarry M.C., Grodstein F. Prospective study of plasma folate, vitamin B12, and cognitive function and decline. Epidemiology 2006, 17:650-657.
35. Kang J.H., Cook N.R., Manson J.E., Buring J.E., Albert C.M., Grodstein F., Vitamin E. vitamin C, beta carotene, and cognitive function among women with or at risk of cardiovascular disease: the Women's Antioxidant and Cardiovascular Study. Circulation 2009, 119:2772-2780.
36. Petersen R.C., Thomas R.G., Grundman M., Bennett D., Doody R., Ferris S., et al. Vitamin E and donepezil for the treatment of mild cognitive impairment. N Engl J Med 2005, 352:2379-2388.
37. DeKosky S.T., Williamson J.D., Fitzpatrick A.L., Kronmal R.A., Ives D.G., Saxton J.A., et al. Ginkgo biloba for prevention of dementia: a randomized controlled trial. JAMA 2008, 300:2253-2262.
38. Troen A.M., Chao W.H., Crivello N.A., D'Anci K.E., Shukitt-Hale B., Smith D.E., et al. Cognitive impairment in folate-deficient rats corresponds to depleted brain phosphatidylcholine and is prevented by dietary methionine without lowering plasma homocysteine. J Nutr 2008, 138:2502-2509.
39. Kivipelto M., Annerbo S., Hultdin J., Backman L., Viitanen M., Fratiglioni L., et al. Homocysteine and holo-transcobalamin and the risk of dementia and Alzheimers disease: a prospective study. Eur J Neurol 2009, 16(7):808-813.
40. Zylberstein D.E., Lissner L., Bjorkelund C., Mehlig K., Thelle D.S., Gustafson D., et al. Midlife homocysteine and late-life dementia in women. A prospective population study. Neurobiol Aging 2009, Epub ahead of print.
41. Sala I., Belen Sanchez-Saudinos M., Molina-Porcel L., Lazaro E., Gich I., Clarimon J., et al. Homocysteine and cognitive impairment. Relation with diagnosis and neuropsychological performance. Dement Geriatr Cogn Disord 2008, 26:506-512.
42. de Lau L.M., Refsum H., Smith A.D., Johnston C., Breteler M.M. Plasma folate concentration and cognitive performance: Rotterdam Scan Study. Am J Clin Nutr 2007, 86:728-734.
43. Wahlin A., Fahlander K., Wahlin T.B., Bunce D., Backman L. Vitamin B status and cognitive performance in preclinical and clinical Alzheimer's disease: data from the Kungsholmen Project. Dement Geriatr Cogn Disord 2008, 25:23-31.
44. Durga J., van Boxtel M.P., Schouten E.G., Kok F.J., Jolles J., Katan M.B., et al. Effect of 3-year folic acid supplementation on cognitive function in older adults in the FACIT trial: a randomised, double blind, controlled trial. Lancet 2007, 369:208-216.
45. Aisen P.S., Schneider L.S., Sano M., Diaz-Arrastia R., van Dyck C.H., Weiner M.F., et al. High-dose B vitamin supplementation and cognitive decline in Alzheimer disease: a randomized controlled trial. JAMA 2008, 300:1774-1783.
46. Rodriguez-Martin J.L., Qizilbash N., Lopez-Arrieta J.M. Thiamine for Alzheimer's disease. Cochrane Database Syst Rev 2001, CD001498.
47. Chan A., Paskavitz J., Remington R., Rasmussen S., Shea T.B. Efficacy of a vitamin/nutriceutical formulation for early-stage Alzheimer's disease: a 1-year, open-label pilot study with a 16-month caregiver extension. Am J Alzheimers Dis Other Demen 2008, 23:571-585.
48. Remington R., Chan A., Paskavitz J., Shea T.B. Efficacy of a vitamin/nutriceutical formulation for moderate-stage to later-stage Alzheimer's disease: a placebo-controlled pilot study. Am J Alzheimers Dis Other Demen 2009, 24:27-33.
49. Berr C., Akbaraly T., Arnaud J., Hininger I., Roussel A.M., Barberger Gateau P. Increased selenium intake in elderly high fish consumers may account for health benefits previously ascribed to omega-3 fatty acids. J Nutr Health Aging 2009, 13:14-18.
50. Niki E. Antioxidant activity: are we measuring it correctly?. Nutrition 2002, 18:524-525.
51. McDaniel M.A., Maier S.F., Einstein G.O. " Brain-specific" nutrients: a memory cure?. Nutrition 2003, 19:957-975.
52. Hollmann W., Struder H.K. Brain function, mind, mood, nutrition, and physical exercise. Nutrition 2000, 16:516-519.
53. Engelhart M.J., Geerlings M.I., Ruitenberg A., van Swieten J.C., Hofman A., Witteman J.C., et al. Dietary intake of antioxidants and risk of Alzheimer disease. JAMA 2002, 287:3223-3229.
54. Hu P., Bretsky P., Crimmins E.M., Guralnik J.M., Reuben D.B., Seeman T.E. Association between serum beta-carotene levels and decline of cognitive function in high-functioning older persons with or without apolipoprotein E 4 alleles: MacArthur studies of successful aging. J Gerontol A Biol Sci Med Sci 2006, 61:616-620.
55. Maxwell C.J., Hicks M.S., Hogan D.B., Basran J., Ebly E.M. Supplemental use of antioxidant vitamins and subsequent risk of cognitive decline and dementia. Dement Geriatr Cogn Disord 2005, 20:45-51.
56. Morris M.C., Evans D.A., Tangney C.C., Bienias J.L., Wilson R.S., Aggarwal N.T., et al. Relation of the tocopherol forms to incident Alzheimer disease and to cognitive change. Am J Clin Nutr 2005, 81:508-514.
57. Zandi P.P., Anthony J.C., Khachaturian A.S., Stone S.V., Gustafson D., Tschanz J.T., et al. Reduced risk of Alzheimer disease in users of antioxidant vitamin supplements: the Cache County Study. Arch Neurol 2004, 61:82-88.
58. Gray S.L., Hanlon J.T., Landerman L.R., Artz M., Schmader K.E., Fillenbaum G.G. Is antioxidant use protective of cognitive function in the community-dwelling elderly?. Am J Geriatr Pharmacother 2003, 1:3-10.
59. Grodstein F., Chen J., Willett W.C. High-dose antioxidant supplements and cognitive function in community-dwelling elderly women. Am J Clin Nutr 2003, 77:975-984.
60. Morris M.C., Evans D.A., Bienias J.L., Tangney C.C., Bennett D.A., Aggarwal N., et al. Dietary intake of antioxidant nutrients and the risk of incident Alzheimer disease in a biracial community study. JAMA 2002, 287:3230-3237.
61. Laurin D., Masaki K.H., Foley D.J., White L.R., Launer L.J. Midlife dietary intake of antioxidants and risk of late-life incident dementia: the Honolulu-Asia Aging Study. Am J Epidemiol 2004, 159:959-967.
62. Luchsinger J.A., Tang M.X., Shea S., Mayeux R. Antioxidant vitamin intake and risk of Alzheimer disease. Arch Neurol 2003, 60:203-208.
63. Sano M., Ernesto C., Thomas R.G., Klauber M.R., Schafer K., Grundman M., et al. A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study. N Engl J Med 1997, 336:1216-1222.
64. Wolters M., Hickstein M., Flintermann A., Tewes U., Hahn A. Cognitive performance in relation to vitamin status in healthy elderly German women-the effect of 6-month multivitamin supplementation. Prev Med 2005, 41:253-259.
65. Kang J.H., Cook N., Manson J., Buring J.E., Grodstein F. A randomized trial of vitamin E supplementation and cognitive function in women. Arch Intern Med 2006, 166:2462-2468.
66. Luchsinger J.A., Tang M.X., Miller J., Green R., Mayeux R. Relation of higher folate intake to lower risk of Alzheimer disease in the elderly. Arch Neurol 2007, 64:86-92.
67. Morris M.C., Evans D.A., Schneider J.A., Tangney C.C., Bienias J.L., Aggarwal N.T. Dietary folate and vitamins B-12 and B-6 not associated with incident Alzheimer's disease. J Alzheimers Dis 2006, 9:435-443.
68. Kado DM, Karlamangla AS, Huang MH, Troen A, Rowe JW, Selhub J, et al. Homocysteine versus the vitamins folate, B6, and B12 as predictors of cognitive function and decline in older high-functioning adults: MacArthur Studies of Successful Aging. Am J Med;118:161-167.
69. Morris M.C., Evans D.A., Bienias J.L., Tangney C.C., Hebert L.E., Scherr P.A., et al. Dietary folate and vitamin B12 intake and cognitive decline among community-dwelling older persons. Arch Neurol 2005, 62:641-645.
70. Tucker K.L., Qiao N., Scott T., Rosenberg I., Spiro A. High homocysteine and low B vitamins predict cognitive decline in aging men: the Veterans Affairs Normative Aging Study. Am J Clin Nutr 2005, 82:627-635.
71. Ravaglia G., Forti P., Maioli F., Martelli M., Servadei L., Brunetti N., et al. Homocysteine and folate as risk factors for dementia and Alzheimer disease. Am J Clin Nutr 2005, 82:636-643.
72. Teunissen C.E., Blom A.H., Van Boxtel M.P., Bosma H., de Bruijn C., Jolles J., et al. Homocysteine: a marker for cognitive performance? A longitudinal follow-up study. J Nutr Health Aging 2003, 7:153-159.
73. Luchsinger J.A., Tang M.X., Shea S., Miller J., Green R., Mayeux R. Plasma homocysteine levels and risk of Alzheimer disease. Neurology 2004, 62:1972-1976.
74. Seshadri S., Beiser A., Selhub J., Jacques P.F., Rosenberg I.H., D'Agostino R.B., et al. Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. N Engl J Med 2002, 346:476-483.
75. McMahon J.A., Green T.J., Skeaff C.M., Knight R.G., Mann J.I., Williams S.M. A controlled trial of homocysteine lowering and cognitive performance. N Engl J Med 2006, 354:2764-2772.
76. Bryan J., Calvaresi E., Hughes D. Short-term folate, vitamin B-12 or vitamin B-6 supplementation slightly affects memory performance but not mood in women of various ages. J Nutr 2002, 132:1345-1356.
77. Sun Y., Lu C.J., Chien K.L., Chen S.T., Chen R.C. Efficacy of multivitamin supplementation containing vitamins B6 and B12 and folic acid as adjunctive treatment with a cholinesterase inhibitor in Alzheimer's disease: a 26-week, randomized, double-blind, placebo-controlled study in Taiwanese patients. Clin Ther 2007, 29:2204-2214.
78. Wang H.X., Wahlin A., Basun H., Fastbom J., Winblad B., Fratiglioni L. Vitamin B(12) and folate in relation to the development of Alzheimer's disease. Neurology 2001, 56:1188-1194.
79. Morris M.C., Evans D.A., Tangney C.C., Bienias J.L., Wilson R.S. Associations of vegetable and fruit consumption with age-related cognitive change. Neurology 2006, 67:1370-1376.
80. Dai Q., Borenstein A.R., Wu Y., Jackson J.C., Larson E.B. Fruit and vegetable juices and Alzheimer's disease: the Kame Project. Am J Med 2006, 119:751-759.
81. Corrada M.M., Kawas C.H., Hallfrisch J., Muller D., Brookmeyer R. Reduced risk of Alzheimer's disease with high folate intake: The Baltimore Longitudinal Study of Aging. Alzheimers Dement 2005, 1:11-18.
82. McNeill G., Avenell A., Campbell M.K., Cook J.A., Hannaford P.C., Kilonzo M.M., et al. Effect of multivitamin and multimineral supplementation on cognitive function in men and women aged 65 years and over: a randomised controlled trial. Nutr J 2007, 6:10.